GRK2 Inhibition Reduces Post-Myocardial Infarction Cardiac Fibroblast-Mediated Adverse Remodeling Jennifer L. Philip 1 , Xianyao Xu 1 ,Mei Han 1 , Jinju Li 2 , Abdur Razzaque 1 , Shahab A. Akhter 1 AATS Lillehei Resident Forum April 27,2015 Divisions of Cardiothoracic Surgery 1 University of Wisconsin & 2 University of Chicago
17
Embed
GRK2 Inhibition Reduces Post-Myocardial Infarction Cardiac Fibroblast-Mediated Adverse Remodeling Jennifer L. Philip 1, Xianyao Xu 1,Mei Han 1, Jinju Li.
Post-Infarction Remodeling Increased Interstitial collagen Adverse Remodeling Heart Failure Adapted From: Zouein FA et al. Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough? Congest Heart Fail Sep-Oct;18(5): Konstam MA et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging Jan;4(1):
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Jennifer L. Philip1, Xianyao Xu1,Mei Han1, Jinju Li2, Abdur Razzaque1, Shahab A. Akhter1
AATS Lillehei Resident ForumApril 27,2015
Divisions of Cardiothoracic Surgery 1University of Wisconsin & 2University of Chicago
Disclosures
None
Post-Infarction Remodeling
Increased Interstitial collagen
Adverse Remodeling
Heart Failure
Adapted From: Zouein FA et al. Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough? Congest Heart Fail. 2012 Sep-Oct;18(5):284-90.Konstam MA et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108.
Adapted From: Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009 Aug, 123(2):255-78.
β-agonist
Adapted from: Paul A Insel, Fiona Murray, Utako Yokoyama, Silvia Romano, Hongruo Yun, Loren Brown, Aaron Snead, David Lu, Nakon Aroonsakool. cAMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol. 2012 May; 166(2): 447–456.
Cardiac Fibroblasts• Cardiac Fibroblasts (CF) make up 60-70% of cells in the heart• CF play a critical role in adverse remodeling • HF phenotype characterized by: differentiation into myofibroblasts and
increased collagen production
Adapted From: Howard A. Rockman, Walter J. Koch & Robert J. Lefkowitz. Seven-transmembrane-spanning receptors and heart function. Nature. 2002 Jan 10;415(6868):206-12.
GPCR uncoupling and endocytosis
GPCR
Phosphorylation and Desensitization
Prolonged Agonist Stimulation
cAMP
Karen M. D'Souza et al. J. Biol. Chem. 2011
0 -7 -6 -50
1000
2000
3000
4000
5000
ControlHF
log [ISO], M[3
H]pr
olin
e in
corp
orat
ion
(cpm
/mg
prot
ein)
* * * *
untreated ISO forskolin0
5
10
15
20
25 ControlHF
cAM
P pr
oduc
tion
(pm
ol/m
L)
#*
GR
K2
Control
Vim
entin
HF
Rhodopsin (38kD)
Control HF0
3
6
9
12
15
18
GRK
2 ac
tivity
(arb
itrar
y u
nits
)
*
Control HF
The Role of β-ARs and GRK2 in CF • β-adrenergic receptor (β-AR) signaling/cAMP inhibits CF-mediated fibrosis • G protein-coupled receptor kinase-2 (GRK2) uncouples β-AR signaling • GRK2 upregulated in human HF
Hypotheses
• GRK2 is upregulated in cardiac fibroblasts post-MI and is a primary etiology of maladaptive ventricular remodeling via uncoupling of β-ARs and decreased intracellular cAMP production
• Inhibition of GRK2 in vivo can decrease post-MI ventricular remodeling and cardiac dysfunction by inhibiting cardiac fibroblast activation and collagen synthesis
Who
le
Hear
tIn
farc
t Ar
eaRe
mot
e Te
rrito
ry
Picrosirius red stain: Collagen stained Red
Con-trol
2 4 8 120%
2%
4%
6%
8%
Weeks Post-MI
Infa
rct F
ibro
tic A
rea
(%)
Control
* * * *
Con-trol
2 4 8 120%
5%
10%
15%
20%
Weeks Post-MIR
emot
e Te
rrito
ry F
ibro
tic A
rea
(%)
*
##
*
2 4 8 12Weeks Post-MI
*p<0.01 vs. Control; n=3-8
*p<0.04 vs. Control, #p<0.01 vs. Control &vs. 2wk Post-MI; n=3-8
Post-MI Ventricular Remodeling
Development of Failing CF Phenotype Post-MI
*
Collagen IGreen
α-SMARed
Control Post-MI
VimentinRed
Nuclei stained Blue with DAPI
Collagen I (134 kDa)
Post-MIControl
Control Post-MI0.0
2.0
4.0
6.0
8.0
10.0
Col
lage
n I/G
APD
H
Expr
essi
on
(rela
tive
units
)
Control Post-MI0.02.04.06.08.0
10.012.014.0
α-SM
A/G
APD
H
Expr
essi
on
(rela
tive
units
) *
*
*p<0.0001 vs. Control; n=4
*p<0.0002 vs. Control; n=3-4
α-SMA (42 kDa)
GAPDH (37 kDa)
*
Increased CF Collagen Synthesis and Uncoupled β–AR signaling Post-MI
*
*
*
**#
*p<0.02 vs. Control + No Drug, **p<0.005 vs. Control + Iso, #p<0.01 vs. Control + TGF-β; n=7-9
*p<0.02 vs. Control; n=3
Control Post-MI0
1000
2000
3000
4000No Drug Iso TGF-β
3[H
]Pro
line
Inco
rpor
atio
n (c
pm/μ
g pr
otei
n)
Control Post-MI 0.0
1.0
2.0
3.0
4.0
5.0
6.0
cAM
P (p
mol
/mL)
*
GRK2 is Upregulated Post-MI
GRK2 (80 kDa)GAPDH (37 kDa)
Control Post-MI
VimentinRed
Nuclei stained Blue with DAPI
GRK2Green
Post-MIControl
Control Post-MI0.00.51.01.52.02.53.0
GR
K2/
GA
PDH
Ex
pres
sion
(rela
tive
units
) *
*p<0.02 vs. Control; n=4
GRK2 (80 kDa)
GAPDH (37kDa)
α-SMA(42 kDa)
GRK2ct (27 kDa)
Control MI+Ad-Null MI+Ad-GRK2ct
GAPDH (37kDa)
Control
MI + Ad-Null
MI + Ad-GRK2ct0.0
0.5
1.0
1.5
2.0
2.5
Fold
Cha
nge
Col
lage
n I
/GA
PDH
Exp
ress
ion
(rel
a-tiv
e un
its)
*
Collagen I (134kDa)GAPDH (37kDa)
Control
MI + Ad-Null
MI + Ad-GRK2ct0.0
0.5
1.0
1.5
2.0
2.5
Fold
Cha
nge
α-SM
A/G
APD
H E
xpre
ssio
n
(rela
tive
units
)
*
Control MI+Ad-Null MI+Ad-GRK2ct
ControlMI+
Ad-NullMI+
Ad-GRK2ct
Inhibition of GRK2 in vivo Decreases Post-MI Activation of Cardiac Fibroblasts
*p<0.02 vs. Control & vs. MI+Ad-GRK2ct, n=5
*p<0.04 vs. Control & vs. MI+Ad-GRK2ct, n=5
*
**
Control MI+Ad-Null MI+Ad-GRK2ct
*
**
Control MI+Ad-Null
MI+Ad-GRK2ct0%
2%
4%
6%
8%
10%
Infa
rct F
ibro
tic
Are
a (%
)Control
MI+Ad-Null MI+Ad-GRK2ct
0%
5%
10%
15%
Rem
ote
Terr
itory
Fib
rotic
Are
a (%
)
Who
le
Hear
tIn
farc
t Ar
eaRe
mot
e Te
rrito
ryInhibition of GRK2 in vivo Decreases
Post-Infarction Ventricular Fibrosis
Picrosirius red stain: Collagen stained Red
*p<0.001 vs. Control, **p<0.002 vs. Ad-Null & vs. Control; n=3-5
*p<0.001 vs. Control, **p<0.002 vs. Ad-Null & vs. Control; n=3-5
***
Control MI+Ad-Null MI+Ad-GRK2ct
Inhibition of GRK2 Preserves Ventricular Function
*p<0.01 vs. Control, **p<0.03 vs. Ad-Null; n=4-5
Control MI+Ad-Null MI+Ad-GRK2ct0%
10%20%30%40%50%60%70%80%90%
Ejec
tion
Frac
tion
(%)
Conclusions
• Post-MI LV remodeling is characterized by significant remote territory fibrosis and CF differentiation and activation
• Uncoupling of β-AR signaling via increased GRK2 appears to be an important mechanism of CF-mediated myocardial fibrosis
• Inhibition of GRK2 decreases cardiac fibroblast transformation and collagen synthesis resulting in decreased maladaptive ventricular remodeling
Future Directions
• Investigation of the potential role of GRK2 in MMP and TIMP biology
• Studying additional regulators of GPCR signaling including β-arrestin in CF biology
• Creation of a fibroblast-specific transgenic mouse model for inhibition of GRK2 to further explore CF-specific inhibition of GRK2 as a potential therapeutic strategy to prevent maladaptive ventricular remodeling
Acknowledgements
• PI – Shahab Akhter, MD
• Lab members– Xianyao Xu– Mei Han – Abdur M. Razzaque, PhD – Tiju Theccanat– Jinju Li, PhD
• University of Wisconsin Department of Surgery• University of Chicago Department of Surgery• Funding:
– Howard Hughes Medical Institute– National Institutes of Health